BBWI250117C45000
- 0.08
- 0.000.00%
Bath & Body Works Newsroom
Bath & Body Works Analyst Ratings
J.P. Morgan Maintains Bath & Body Works(BBWI.US) With Hold Rating, Raises Target Price to $41
BofA Securities Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $45
Analysts Offer Insights on Consumer Cyclical Companies: Carnival (CCL), Bath & Body Works (BBWI) and Yum! Brands (YUM)
Morgan Stanley Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $49
Morgan Stanley Sticks to Their Buy Rating for Bath & Body Works (BBWI)
Wells Fargo Upgrades Bath & Body Works(BBWI.US) to Buy Rating, Raises Target Price to $48
Bath & Body Works Analyst Ratings
Piper Sandler Maintains Neutral on Bath & Body Works, Raises Price Target to $39
Piper Sandler Maintains Bath & Body Works(BBWI.US) With Hold Rating, Raises Target Price to $39
Goldman Sachs Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $52
Analysts Conflicted on These Consumer Cyclical Names: Bath & Body Works (BBWI) and Vail Resorts (MTN)
Bath & Body Works Is Maintained at Buy by TD Cowen
Bath & Body Works Analyst Ratings
Wells Fargo Maintains Bath & Body Works(BBWI.US) With Hold Rating, Raises Target Price to $42
Wells Fargo Reaffirms Their Hold Rating on Bath & Body Works (BBWI)
TD Cowen Maintains Bath & Body Works(BBWI.US) With Buy Rating, Raises Target Price to $48
A Quick Look at Today's Ratings for Bath & Body Works(BBWI.US), With a Forecast Between $34 to $52
Barclays raises Bath & Body Works' target price to $34.
Bath & Body Works Price Target Raised to $38.00/Share From $32.00 by Wells Fargo